Dolby Laboratories (NYSE:DLB) Cut to “Hold” at Wall Street Zen

04 Aug 2026, 01:30 by Scott Moore · The Cerbat Gem

Wall Street Zen lowered shares of Dolby Laboratories (NYSE:DLB – Free Report) from a buy rating to a hold rating in a research report report published on Saturday.

A number of other research analysts have also issued reports on the company. Barrington Research reiterated an “outperform” rating and issued a $90.00 target price on shares of Dolby Laboratories in a report on Monday, June 15th. Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Wednesday, June 24th. Finally, Rosenblatt Securities restated a “buy” rating and set a $85.00 price target on shares of Dolby Laboratories in a report on Friday. Three research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $90.75.

Read Our Latest Research Report on DLB

Dolby Laboratories Stock Up 1.5%

Dolby Laboratories stock opened at $59.70 on Friday. The firm has a market cap of $5.65 billion, a PE ratio of 25.40 and a beta of 0.80. Dolby Laboratories has a 52-week low of $48.26 and a 52-week high of $75.66. The company’s 50 day moving average is $52.39 and its two-hundred day moving average is $58.51.

Dolby Laboratories (NYSE:DLB – Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The electronics maker reported $0.69 EPS for the quarter, beating the consensus estimate of $0.67 by $0.02. The company had revenue of $305.00 million during the quarter, compared to analysts’ expectations of $311.96 million. Dolby Laboratories had a net margin of 16.70% and a return on equity of 11.08%. The firm’s revenue was down 3.3% compared to the same quarter last year. During the same quarter last year, the company posted $0.78 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. On average, equities research analysts anticipate that Dolby Laboratories will post 3.21 earnings per share for the current fiscal year.

Dolby Laboratories announced that its board has approved a stock buyback plan on Thursday, July 30th that authorizes the company to buyback $350.00 million in shares. This buyback authorization authorizes the electronics maker to purchase up to 7% of its shares through open market purchases. Shares buyback plans are often an indication that the company’s leadership believes its shares are undervalued.

Dolby Laboratories Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, August 19th. Stockholders of record on Tuesday, August 11th will be issued a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date of this dividend is Tuesday, August 11th. Dolby Laboratories’s dividend payout ratio is presently 61.28%.

Insider Activity

In other Dolby Laboratories news, SVP John D. Couling sold 7,667 shares of the business’s stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $53.20, for a total transaction of $407,884.40. Following the sale, the senior vice president directly owned 118,727 shares in the company, valued at approximately $6,316,276.40. The trade was a 6.07% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Robert J. Park sold 4,895 shares of the business’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $56.68, for a total transaction of $277,448.60. Following the completion of the sale, the chief financial officer owned 81,490 shares in the company, valued at $4,618,853.20. This represents a 5.67% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 35,104 shares of company stock worth $1,924,252 over the last quarter. Insiders own 37.93% of the company’s stock.

Institutional Trading of Dolby Laboratories

Hedge funds and other institutional investors have recently bought and sold shares of the company. Fifth Third Bancorp grew its holdings in shares of Dolby Laboratories by 34.7% during the 4th quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock worth $48,000 after purchasing an additional 192 shares during the period. Aquatic Capital Management LLC purchased a new position in Dolby Laboratories in the 3rd quarter worth approximately $56,000. iSAM Funds UK Ltd purchased a new position in Dolby Laboratories in the 3rd quarter worth approximately $68,000. Quarry LP grew its position in Dolby Laboratories by 1,486.7% in the fourth quarter. Quarry LP now owns 1,190 shares of the electronics maker’s stock valued at $76,000 after acquiring an additional 1,115 shares in the last quarter. Finally, Farther Finance Advisors LLC grew its position in Dolby Laboratories by 48.4% in the fourth quarter. Farther Finance Advisors LLC now owns 1,232 shares of the electronics maker’s stock valued at $79,000 after acquiring an additional 402 shares in the last quarter. 58.56% of the stock is owned by hedge funds and other institutional investors.

About Dolby Laboratories

(Get Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.